Transcription factor Egr-1 is essential for maximal matrix metalloproteinase-9 transcription by tumor necrosis factor α

Molecular Cancer Research

Volumn 8, Issue 4, 2010, Pages 507-519

  Shin, Soon Young ^a,b   Kim, Ji Ho ^b   Baker, Andrew ^c   Lim, Yoongho ^b   Lee, Young Han ^a,b  

^a Konkuk University Hospital   (South Korea)

^b Konkuk University   (South Korea)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P300; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR EGR 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CANCER CELL; CONTROLLED STUDY; EMBRYO; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NF-KAPPA B; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951183754     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0454     Document Type: Article

References (53)

1. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006;25:9-34.
2. Johansson N, Ahonen M, Kahari VM. Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 2000;57:5-15.
3. Van den Steen P, Dubois B, Nelissen I, Rudd P, Dwek R, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 2002;37:375-536.
4. Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-744
5. Vu T, Shipley J, Bergers G, et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998;93:411-422
6. Lin L-F, Chuang C-H, Li C-F, et al. ZBRK1 acts as a metastatic suppressor by directly regulating MMP9 in cervical cancer. Cancer Res 2010;70:192-201.
7. Song H, Li Y, Lee J, Schwartz A, Bu G. Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9. Cancer Res 2009;69:879-886
8. Kupferman M, Fini M, Muller W, Weber R, Cheng Y, Muschel R. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol 2000;157:1777-1783
9. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-867
10. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009;9:239-252
11. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer 2009;9:361-371
12. Holvoet S, Vincent C, Schmitt D, Serres M. The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-α in human keratinocytes. Exp Cell Res 2003;290:108-119
13. Lin C, Tseng H, Hsieh H, et al. Tumor necrosis factor-α induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-κB in A549 cells. Toxicol Appl Pharmacol 2008;229:386-398
14. Ray A, Bal B, Ray B. Transcriptional induction of matrix metalloproteinase-9 in the chondrocyte and synoviocyte cells is regulated via a novel mechanism: evidence for functional cooperation between serum amyloid A-activating factor-1 and AP-1. J Immunol 2005;175:4039-4048
15. Rao V, Singh R, Delimont D, et al. Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-α Int J Oncol 1999;14:291-300.
16. Rockel J, Bernier S, Leask A. Egr-1 inhibits the expression of extracellular matrix genes in chondrocytes by TNFá-induced MEK/ERK signalling. Arthritis Res Ther 2009;11:R8.
17. Sato H, Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993;8:395-405.
18. Benbow U, Brinckerhoff C. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 1997;15:519-526
19. Bond M, Fabunmi R, Baker A, Newby A. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-κB. FEBS lett 1998;435:29-34.
20. Ning W, Dong Y, Sun J, et al. Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts. Am J Respir Cell Mol Biol 2007;36:480-490
21. Haas TL, Stitelman D, Davis SJ, Apte SS, Madri JA. Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J Biol Chem 1999;274:22679-22685
22. Barbolina MV, Adley BP, Ariztia EV, Liu Y, Stack MS. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression. J Biol Chem 2007;282:4924-4931
23. Cao XM, Guy GR, Sukhatme VP, Tan YH. Regulation of the Egr-1 gene by tumor necrosis factor and interferons in primary human fibroblasts. J Biol Chem 1992;267:1345-1349
24. Son SW, Min BW, Lim Y, Lee YH, Shin SY. Regulatory mechanism of TNFα autoregulation in HaCaT cells: the role of the transcription factor EGR-1. Biochem Biophys Res Commun 2008;374:777-782
25. Grimbacher B, Aicher WK, Peter HH, Eibel H. TNF-α induces the transcription factor Egr-1, pro-inflammatory cytokines and cell proliferation in human skin fibroblasts and synovial lining cells. Rheumatol Int 1998;17:185-192
26. Chaudhary LR, Cheng SL, Avioli LV. Induction of early growth response-1 gene by interleukin-1β and tumor necrosis factor-á in normal human bone marrow stromal an osteoblastic cells: regulation by a protein kinase C inhibitor. Mol Cell Biochem 1996;156:69-77.
27. Lee SL, Tourtellotte LC, Wesselschmidt RL, Milbrandt J. Growth and differentiation proceeds normally in cells deficient in the immediate early gene NGFI-A. J Biol Chem 1995;270:9971-9977
28. Yang SH, Sharrocks AD. PIASx acts as an Elk-1 coactivator by facilitating derepression. EMBO J 2005;24:2161-2171
29. Choi BH, Kim CG, Bae YS, Lim Y, Lee YH, Shin SY. p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression. Cancer Res 2008;68:1369-1377
30. Utreras E, Futatsugi A, Rudrabhatla P, et al. Tumor necrosis factorα regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. J Biol Chem 2009;284:2275-2284
31. Mishra JP, Mishra S, Gee K, Kumar A. Differential involvement of calmodulin-dependent protein kinase II-activated AP-1 and c-Jun N-terminal kinase-activated EGR-1 signaling pathways in tumor necrosis factor-α and lipopolysaccharide-induced CD44 expression in human monocytic cells. J Biol Chem 2005;280:26825-26837
32. Milbrandt J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 1987;238:797-799
33. Silverman ES, Collins T. Pathways of Egr-1-mediated gene transcription in vascular biology. Am J Pathol 1999;154:665-670
34. Sukhatme VP, Cao XM, Chang LC, et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 1988;53:37-43.
35. Liu C, Rangnekar VM, Adamson E, Mercola D. Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther 1998;5:3-28.
36. Huang RP, Fan Y, de BI, et al. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 1997;72:102-109
37. Huang RP, Fan Y, Peng A, et al. Suppression of human fibrosarcoma cell growth by transcription factor, Egr-1, involves down-regulation of Bcl-2. Int J Cancer 1998;77:880-886
38. Calogero A, Arcella A, De Gregorio G, et al. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res 2001;7:2788-2796
39. Levin WJ, Press MF, Gaynor RB, et al, The Lung Cancer Study Group. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. Oncogene 1995;11:1261-1269
40. Krones-Herzig A, Mittal S, Yule K, et al. Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. Cancer Res 2005;65:5133-5143
41. Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED, Mercola D. Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes. J Biol Chem 2003;278:11802-11810
42. Baron V, Duss S, Rhim J, Mercola D. Antisense to the early growth response-1 gene (Egr-1) inhibits prostate tumor development in TRAMP mice. Ann NY Acad Sci 2003;1002:197-216.
43. Silverman ES, Du J, Williams AJ, Wadgaonkar R, Drazen JM, Collins T. cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1). Biochem J 1998;336:183-189
44. Yu J, de Belle I, Liang H, Adamson ED. Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol Cell 2004;15:83-94.
45. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A 1997;94:2927-2932
46. Zhao X, Benveniste E. Transcriptional activation of human matrix metalloproteinase-9 gene expression by multiple co-activators. J Mol Biol 2008;383:945-956
47. Huang RP, Fan Y, Ni Z, Mercola D, Adamson ED. Reciprocal modulation between Sp1 and Egr-1. J Cell Biochem 1997;66:489-499
48. Mackay A, Ballin M, Pelina M, et al. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 1992;12:168-184
49. Qin H, Moellinger J, Wells A, Windsor L, Sun Y, Benveniste E. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-α and IFN-γ. J Immunol 1998;161:6664-6673
50. Ikebe T, Takeuchi H, Jimi E, Beppu M, Shinohara M, Shirasuna K. Involvement of proteasomes in migration and matrix metalloproteinase-9 production of oral squamous cell carcinoma. Int J Cancer 1998;77:578-585
51. Salo T, Larjava H. MMP-9 from TNFα-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation? Biochem Biophys Res Commun 1998;253:325-335
52. Lockwood C, Oner C, Uz Y, et al. Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor α and interleukin 1β in human first trimester decidual cells1. Biol Reprod 2008;78:1064-1072
53. Ling Z, Chunli Y, Roben G, et al. Tumor necrosis factor-α induced expression of matrix metalloproteinase-9 through p21-activated kinase-1. BMC Immunol 2009;10:15.